Brand
Amring Pharmaceuticals Inc
1 federal recall on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Amring Pharmaceuticals Inc and translate it into plain English — free weekly digest, optional same-day alerts.
- 2023-06-21FDA-DrugClass IIILysteda (tranexamic acid) USP Tablets, 650 mg, 30 tablets per bottle, Rx Only, Manufactured for: Amring Pharmaceuticals Inc. Berwyn, PA 19312, NDC 69918-301-30
Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.
Get notified about new Amring Pharmaceuticals Inc recalls
Free weekly digest. We email when a new federal recall affects Amring Pharmaceuticals Inc or anything else in your household.
Get the Sunday BriefExplore other recall topics
By hazard
By state